Alagha Ibrahim, Doman Ghadeer, Aouthmanyzx Shaza
Ohio University Heritage College of Osteopathic Medicine, Athens, OH.
King Abdulaziz University, College of Medicine, Department of Emergency Medicine, Jeddah, Saudi Arabia.
J Educ Teach Emerg Med. 2022 Oct 15;7(4):S1-S26. doi: 10.21980/J8PH1B. eCollection 2022 Oct.
The targeted audience for this simulation are emergency medicine providers, including residents as well as advanced practice providers, to properly educate on recognizing, diagnosing, and managing methemoglobinemia.
Methemoglobinemia is a blood disorder characterized by the presence of ferric form of hemoglobin in the blood. This form of hemoglobin can carry oxygen but is unable to release it effectively causing a range of symptoms including headache, dizziness, nausea, and cyanosis. It is rarely congenital and mostly caused by the exposure to oxidizing agents, such as local anesthetics and quinolones.1 Normally, oxygen can bind to hemoglobin while it is in the ferrous state (Fe2+). In cases of methemoglobinemia, the heme iron configuration is converted from ferrous (Fe2+) to ferric (Fe3+), making it unable to bind to oxygen. As a result, normal ferrous hemes experience an increased affinity for oxygen causing a leftward shift in the oxygen dissociation curve. This in turn causes functional anemia due to reduced oxygen carrying capacity.1 Methemoglobinemia can result from exposure to different medications as well as environmental factors and presents like other disease processes including chronic obstructive pulmonary disease exacerbations. Congenital methemoglobinemia due to cytochrome b5 reductase deficiency is very rare, but the actual incidence is not known. Increased frequency of disease has been found in Siberian Yakuts, Athabaskans, Eskimos, and Navajo.2 Although it is also an unusual occurrence, acquired methemoglobinemia is much more frequently encountered than the congenital form.1In a 10-year retrospective study looking at the incidence rate of topical anesthetic-induced methemoglobinemia, it was found that the overall prevalence was 0.035%. A major risk factor was hospitalization at the time of a procedure being performed. An increased risk was also seen with benzocaine-based anesthetics.3.
At the end of this simulation case, participants should be able to: 1) recognize shortness of breath, cyanosis and respiratory distress, and the difference between all of them based on the clinical presentation 2) identify the underlying cause of the condition by conducting a thorough history and physical 3) know how to identify and treat methemoglobinemia by ordering necessary labs and interventions and understand the pathophysiology leading to methemoglobinemia 4) recognize patient's response to treatment and continue to reassess.
This is a high-fidelity simulation case that allows participants to evaluate and treat methemoglobinemia in a safe environment. The case is followed by a debriefing and small group discussion to review patient care skills, medical knowledge, interpersonal communication, practice-based learning, and improvement.
The educational content and efficacy were evaluated by oral feedback and a debriefing session immediately after completion of the simulation. A 5-point Likert scale was sent out to participants pre-simulation and post-simulation. Questions on the survey included whether they felt confident in their ability to recognize methemoglobinemia, understood the physiology and causes of methemoglobinemia, and felt confident in their ability to treat methemoglobinemia.
Sixteen learners responded to the survey, consisting of EM residents and medical students. Post simulation, approximately 92% of EM residents answered agree or strongly agree in their ability to recognize and treat methemoglobinemia compared to pre-sim survey of about 62.5%. Post-simulation feedback also resulted in positive reception, and learners found it useful to run through an uncommonly seen case in the hospital. Results showed overall improvement in recognition and treatment of methemoglobinemia among residents and medical students.
This simulation improved recognition of methemoglobinemia including signs and symptoms associated with it. Proper management and treatment options were included such as administration of methylene blue. Overall, this simulation was helpful in teaching EM residents how to recognize, manage, and treat methemoglobinemia. In addition, post-simulation debriefing allowed further discussion among residents, which they found valuable.
Methemoglobinemia, shortness of breath, cyanosis, respiratory distress, anemia, methemoglobin, oxygen dissociation curve, emergency medicine simulation.
本次模拟的目标受众是急诊医学从业者,包括住院医师以及高级执业医师,旨在对他们进行关于高铁血红蛋白血症的识别、诊断和管理的适当培训。
高铁血红蛋白血症是一种血液疾病,其特征是血液中存在高铁形式的血红蛋白。这种形式的血红蛋白能够携带氧气,但无法有效释放,从而导致一系列症状,包括头痛、头晕、恶心和发绀。它很少是先天性的,主要由接触氧化剂引起,如局部麻醉剂和喹诺酮类药物。1正常情况下,氧气在血红蛋白处于亚铁状态(Fe2+)时可以与之结合。在高铁血红蛋白血症病例中,血红素铁构型从亚铁(Fe2+)转化为高铁(Fe3+),使其无法与氧气结合。结果,正常的亚铁血红素对氧气的亲和力增加,导致氧解离曲线向左移动。这进而由于氧携带能力降低而导致功能性贫血。1高铁血红蛋白血症可能由接触不同药物以及环境因素引起,其表现与其他疾病过程相似,包括慢性阻塞性肺疾病急性加重。由于细胞色素b5还原酶缺乏导致的先天性高铁血红蛋白血症非常罕见,但其实际发病率尚不清楚。在西伯利亚雅库特人、阿萨巴斯卡人、爱斯基摩人和纳瓦霍人中发现该病的发病率增加。2虽然这也是一种不常见的情况,但获得性高铁血红蛋白血症比先天性形式更为常见。1在一项为期10年的回顾性研究中,观察局部麻醉剂引起的高铁血红蛋白血症的发病率,发现总体患病率为0.035%。一个主要风险因素是在进行手术时住院。使用基于苯佐卡因的麻醉剂时风险也会增加。3.
在本模拟病例结束时,参与者应能够:1)识别呼吸急促、发绀和呼吸窘迫,并根据临床表现区分它们之间的差异;2)通过全面的病史和体格检查确定病情的潜在原因;3)知道如何通过安排必要的实验室检查和干预措施来识别和治疗高铁血红蛋白血症,并了解导致高铁血红蛋白血症的病理生理学;4)识别患者对治疗的反应并继续进行重新评估。
这是一个高保真模拟病例,使参与者能够在安全环境中评估和治疗高铁血红蛋白血症。病例之后是汇报和小组讨论,以回顾患者护理技能、医学知识、人际沟通、基于实践的学习和改进。
在模拟完成后,通过口头反馈和汇报会议对教育内容和效果进行评估。在模拟前和模拟后向参与者发送一份5点李克特量表。调查中的问题包括他们是否对自己识别高铁血红蛋白血症的能力有信心、是否理解高铁血红蛋白血症的生理学和病因,以及是否对自己治疗高铁血红蛋白血症的能力有信心。
16名学习者回复了调查,包括急诊医学住院医师和医学生。模拟后,约92%的急诊医学住院医师在识别和治疗高铁血红蛋白血症的能力方面回答同意或强烈同意,而模拟前的调查中这一比例约为62.5%。模拟后的反馈也得到了积极的回应,学习者发现演练医院中不常见的病例很有用。结果显示住院医师和医学生在高铁血红蛋白血症的识别和治疗方面总体有所改善。
本次模拟提高了对高铁血红蛋白血症及其相关体征和症状的识别。包括了适当的管理和治疗选择,如亚甲蓝的给药。总体而言,本次模拟有助于教导急诊医学住院医师如何识别、管理和治疗高铁血红蛋白血症。此外,模拟后的汇报允许住院医师之间进行进一步讨论,他们认为这很有价值。
高铁血红蛋白血症、呼吸急促、发绀、呼吸窘迫、贫血、高铁血红蛋白、氧解离曲线、急诊医学模拟